Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular diagnostics in endocrine diseases].

Jens P Berg1, Robert Bjerknes

  • 1Hormonlaboratoriet, Aker universitetssykehus, 0514 Oslo. j.p.berg@medisin.uio.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|November 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Per- and Polyfluoroalkyl Substance Exposure Associated with Later Puberty in Norwegian Girls: Data from the Bergen Growth Study 2.

Environment & health (Washington, D.C.)·2026
Same author

Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.

British journal of cancer·2026
Same author

Associations Between Weight-Related Measurements and Pubertal Markers in Norwegian Girls: The Bergen Growth Study 2.

Journal of the Endocrine Society·2025
Same author

PCSK1N as a Tumor Size Marker and an ER Stress Response Protein in Corticotroph Pituitary Adenomas.

The Journal of clinical endocrinology and metabolism·2024
Same author

Exposure to Per- and Polyfluoroalkyl Substances and Timing of Puberty in Norwegian Boys: Data from the Bergen Growth Study 2.

Environmental science & technology·2024
Same author

First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial.

British journal of cancer·2024

Molecular diagnostics are crucial for understanding rare genetic mutations in endocrine disorders. These advanced techniques improve diagnosis specificity, guiding tailored treatment and follow-up for patients.

Area of Science:

  • Endocrinology
  • Molecular Genetics
  • Clinical Diagnostics

Context:

  • Endocrine disorders often stem from genetic mutations affecting hormone production, secretion, or signaling.
  • While rare, these mutations are key to understanding specific pathophysiological mechanisms.
  • Common endocrine conditions also have significant, yet often uncharacterized, genetic underpinnings.

Purpose:

  • To review the clinical implications of molecular diagnostics in various endocrine diseases.
  • To highlight how molecular diagnostics enhance diagnostic specificity.
  • To underscore the role of genetic insights in managing endocrine conditions.

Summary:

  • Molecular diagnostics offer unparalleled insights into the genetic basis of endocrine disorders.

Related Experiment Videos

  • The review details applications in congenital adrenal hyperplasia, hypothyroidism, thyroid hormone resistance, familial hypocalciuric hypercalcemia, growth hormone disorders, and monogenic obesity.
  • Specific genetic diagnoses directly impact patient management and therapeutic strategies.

    • Impact:

    • Enhanced diagnostic specificity leads to more precise treatment plans and improved patient follow-up.
    • Molecular diagnostics are transforming the clinical approach to rare and common endocrine diseases.
    • This review serves as a foundation for understanding the clinical utility of genetic testing in endocrinology.